| Congenital Trypanosoma cruzi Transmission in Santa Cruz, Bolivia C Bern, M Verastegui, RH Gilman, C LaFuente, G Galdos-Cardenas, ... Clinical Infectious Diseases 49 (11), 1667-1674, 2009 | 215 | 2009 |
| Chagas cardiomyopathy in the context of the chronic disease transition AI Hidron, RH Gilman, J Justiniano, AJ Blackstock, C LaFuente, W Selum, ... PLoS neglected tropical diseases 4 (5), e688, 2010 | 91 | 2010 |
| A peculiar mutation spectrum emerging from young Peruvian patients with hepatocellular carcinoma A Marchio, S Bertani, T Rojas Rojas, F Doimi, B Terris, E Deharo, ... PLoS One 9 (12), e114912, 2014 | 47 | 2014 |
| Herbal medicine practices of patients with liver cancer in Peru: a comprehensive study toward integrative cancer management T Rojas Rojas, G Bourdy, E Ruiz, JP Cerapio, P Pineau, J Gardon, ... Integrative Cancer Therapies 17 (1), 52-64, 2018 | 39 | 2018 |
| Spectrum and Incidence Trends of AIDS-and Non–AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort I Poizot-Martin, C Lions, C Allavena, T Huleux, F Bani-Sadr, A Cheret, ... Cancer Epidemiology, Biomarkers & Prevention 30 (3), 554-563, 2021 | 34 | 2021 |
| Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project TR Rojas, V Di Beo, J Delorme, T Barre, P Mathurin, C Protopopescu, ... International Journal of Drug Policy 72, 61-68, 2019 | 33 | 2019 |
| Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru E Ruiz, TR Rojas, F Berrospi, I Chávez, C Luque, L Cano, F Doimi, ... Heliyon 2 (1), 2016 | 33 | 2016 |
| Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study) T Barré, F Marcellin, V Di Beo, J Delorme, T Rojas Rojas, P Mathurin, ... Addiction 115 (3), 573-582, 2020 | 27 | 2020 |
| A 13-year retrospective study on primary liver cancer in Cambodia: a strikingly high hepatitis C occurrence among hepatocellular carcinoma cases F Chassagne, T Rojas Rojas, S Bertani, G Bourdy, S Eav, E Ruiz, ... Oncology 91 (2), 106-116, 2016 | 22 | 2016 |
| Outbreak of Infection by Extended-Spectrum β-Lactamase SHV-5-Producing Serratia marcescens in a Mexican Hospital LEE De Los Monteros, J Silva-Sanchez, LV Jiménez, T Rojas, ... Journal of Chemotherapy 20 (5), 586-592, 2008 | 18 | 2008 |
| Alternative management for gynecological cancer care during the COVID‐2019 pandemic: A Latin American survey J Rodriguez, A Fletcher, F Heredia, R Fernandez, H Ramírez Salazar, ... International Journal of Gynecology & Obstetrics 150 (3), 368-378, 2020 | 15 | 2020 |
| Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting C Deschanvres, J Reynes, I Lamaury, D Rey, R Palich, F Bani-Sadr, ... Journal of Antimicrobial Chemotherapy 77 (1), 196-204, 2022 | 14 | 2022 |
| Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline-and taxane-pretreated metastatic breast cancer LT Vahdat, E Vrdoljak, H Gómez, RK Li, L Bosserman, JA Sparano, ... Journal of geriatric oncology 4 (4), 346-352, 2013 | 13 | 2013 |
| Microelimination or not? The changing epidemiology of human immunodeficiency virus-hepatitis C virus coinfection in France 2012–2018 L Cotte, L Hocqueloux, M Lefebvre, P Pradat, F Bani-Sadr, T Huleux, ... Clinical Infectious Diseases 73 (9), e3266-e3274, 2021 | 12 | 2021 |
| Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH) T Barre, T Rojas Rojas, K Lacombe, C Protopopescu, I Poizot-Martin, ... Expert Review of Anti-infective Therapy 19 (9), 1147-1156, 2021 | 11 | 2021 |
| Molecular Characterization of Integron Class 1 (In196) Encoding the VIM-2 Metallo-β-Lactamase of pseudomonas aeruginosa Isolated from a Hospital Environment U Garza-Ramos, P Tinoco, T Rojas, B Carrillo, JM Barajas, S Suarez, ... Journal of Chemotherapy 21 (5), 590-591, 2009 | 11 | 2009 |
| Sleep disturbances in HIV-HCV coinfected patients: indications for clinical management in the HCV cure era (ANRS CO13 HEPAVIH cohort) M Costa, TR Rojas, D Lacoste, V Villes, H Aumaitre, C Protopopescu, ... European Journal of Gastroenterology & Hepatology 31 (12), 1508-1517, 2019 | 10 | 2019 |
| Prevalence and spectrum of second primary malignancies among people living with HIV in the French Dat’AIDS cohort I Poizot-Martin, C Lions, C Delpierre, A Makinson, C Allavena, A Fresard, ... Cancers 14 (2), 401, 2022 | 8 | 2022 |
| Elevated Fatty Liver Index as a Risk Factor for All‐Cause Mortality in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients (ANRS CO13 HEPAVIH Cohort Study) T Barre, C Protopopescu, F Bani‐Sadr, L Piroth, T Rojas Rojas, ... Hepatology 71 (4), 1182-1197, 2020 | 8 | 2020 |
| Bacterial Resistance Consortium and Garza-Ramos, U.(2011) Prevalence and characterization of plasmid-mediated quinolone resistance genes in extended-spectrum β-lactamase … J Silva-Sanchez, H Barrios, F Reyna-Flores, M Bello-Diaz, ... Microb. Drug. Resist 17, 497-505, 0 | 7 | |